Kilitch Drugs (India) Limited reports a change in its board or management
In short
Kilitch Drugs (India) Limited informed the NSE that a director/KMP/SMP has resigned. In simple terms, the company is telling investors that one of its key management personnel has stepped down, which can affect how the company is run. No figures, breakdowns, dates, scheme names, or validity periods are stated in the text.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.